Potential of endogenous regenerative technology for in situ regenerative medicine

A new hope for a therapy against retinitis pigmentosa

Antabuse may help revive vision in people with progressive blinding disorders

New Treatments for Retinitis Pigmentosa

FDA grants orphan drug designation for RP treatment

FDA grants fourth ODD for treatment of PDE6B gene mutation-associated retinal diseases

Understanding the molecular mechanisms underlying retina degeneration in INPP5E-Joubert Syndrome

First Gene Therapy FDA-Approved for an Inherited Retinal Disease

FDA Approves Gene Therapy for Inherited Blindness Developed by the UPenn and CHOP

Stem Cell Therapy: Novel Approach, RP Vision Restoration

Scientists for the First Time Regenerate Sections of Retinas and Increase Visual Function With Stem

Regenerative Therapy for Retinal Disorders